Cargando…

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey

PURPOSE/INTRODUCTION: The Canadian Hypertension Education Program (CHEP) has identified blood pressure (BP) control as a key target for an overall reduction in cardiovascular disease risk. The POWER survey (Physicians’ Observational Work on Patient Education According to their Vascular Risk) used Fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrella, Robert J, Tremblay, Guy, De Backer, Guy, Gill, Dawn P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908905/ https://www.ncbi.nlm.nih.gov/pubmed/24493928 http://dx.doi.org/10.2147/VHRM.S55298

Ejemplares similares

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
por: Petrella, Robert J, et al.
Publicado: (2015)

Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey
por: De Backer, Guy, et al.
Publicado: (2013)

Effects of Eprosartan on Target Organ Protection
por: de la Sierra, Alejandro
Publicado: (2006)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Lichenoid drug eruption due to eprosartan/hydrochlorothiacide
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury
por: Weymann, Alexander, et al.
Publicado: (2014)

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension
por: Rizos, Evangelos C, et al.
Publicado: (2007)

Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
por: Blankestijn, P. J, et al.
Publicado: (2008)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography
por: Patel, Harsha U., et al.
Publicado: (2011)

Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate
por: Ahad, Abdul, et al.
Publicado: (2017)

Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study
por: Dogan, Meeshanthini V., et al.
Publicado: (2018)

Weak Prediction Power of the Framingham Risk Score for Coronary Artery Disease in Nonagenarians
por: Yayan, Josef
Publicado: (2014)

Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology
por: Ahad, Abdul, et al.
Publicado: (2022)

ASSOCIATION OF COGNITION AND SMARTPHONE SURVEY ATTRIBUTES IN THE ELECTRONIC FRAMINGHAM HEART STUDY
por: Pathiravasan, Chathurangi, et al.
Publicado: (2022)

Obesity Phenotype and Coronary Heart Disease Risk as Estimated by the Framingham Risk Score
por: Park, Yong Soon, et al.
Publicado: (2012)

Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults
por: Rodondi, Nicolas, et al.
Publicado: (2012)

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
por: Goudev, Assen, et al.
Publicado: (2012)

Canadian children's independent mobility during the COVID-19 pandemic: A national survey
por: Larouche, Richard, et al.
Publicado: (2023)

Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011)

Digital Connectedness in the Framingham Heart Study
por: Fox, Caroline S., et al.
Publicado: (2016)

Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort
por: Yan, Yu, et al.
Publicado: (2009)

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
por: Joshi, Parag H., et al.
Publicado: (2016)

Adding multiple risk factors improves Framingham coronary heart disease risk scores
por: Hu, Guizhou, et al.
Publicado: (2014)

The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results
por: Ploughman, Michelle, et al.
Publicado: (2014)

Power of linkage analysis using traits generated from simulated longitudinal data of the Framingham Heart Study
por: Wang, Dai, et al.
Publicado: (2003)

Prediction of Risk Factors for Coronary Heart Disease Using Framingham Risk Score in Korean Men
por: Ryoo, Jae-Hong, et al.
Publicado: (2012)

A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study
por: Bhargava, Alok
Publicado: (2003)

Factors Related to Coronary Heart Disease Risk Among Men: Validation of the Framingham Risk Score
por: Gander, Jennifer, et al.
Publicado: (2014)

Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study
por: Hoffmann, Udo, et al.
Publicado: (2016)

Pedigree and genotype errors in the Framingham Heart Study
por: Brush, Gerry, et al.
Publicado: (2003)

Transmission-ratio distortion in the Framingham Heart Study
por: Paterson, Andrew D, et al.
Publicado: (2009)

Copy number variation in the Framingham Heart Study
por: Shtir, Corina, et al.
Publicado: (2009)

Trends in Diabetes Incidence: The Framingham Heart Study
por: Abraham, Tobin M., et al.
Publicado: (2015)

Consistency of linkage results across exams and methods in the Framingham Heart Study
por: Atwood, Larry D, et al.
Publicado: (2003)

Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey
por: Kang, Hye Mi, et al.
Publicado: (2012)

Developing a coordinated Canadian post-secondary surveillance system: a Delphi survey to identify measurement priorities for the Canadian Campus Wellbeing Survey (CCWS)
por: Faulkner, Guy, et al.
Publicado: (2019)

Patterns of Abdominal Fat Distribution: The Framingham Heart Study
por: Pou, Karla M., et al.
Publicado: (2009)

Growth mixture modelling in families of the Framingham Heart Study
por: Kerner, Berit, et al.
Publicado: (2009)

Carotid Atherosclerosis and Cerebral Microbleeds: The Framingham Heart Study
por: Romero, José R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qgicpcrbj4o45uv1h4ioju223o